First two journals in the new Nature Progress series go live
London | New York | Berlin 2nd April 2026
The first two journals in the new Nature-branded journal series Nature Progress, are now live. Nature Progress Brain Health and Nature Progress Oncology will broaden author choice and expand access to high‑quality research, accelerating progress in these critical research fields.
Led by specialist in-house editors, the two new series journals will also draw upon the expertise of Editorial Board Members, who will advise on editorial suitability, support the peer review process and help develop content ideas and collection topics. This collaborative approach ensures rigorous standards while reflecting the diversity of global research.
Nature Progress Oncology will publish high-quality primary research across basic, translational and clinical oncology. The journal launches at a time when cancer incidence is rising significantly, with predictions of a 77% increase through 2050 from the estimated 20 million cases in 2022 (data from WHO/IARC). This underscores the urgent need for new research and treatments to improve survival and quality of life. The journal will be led by Deputy Editor Kathryn McGinnis.
Nature Progress Brain Health will span translational neuroscience, neurology and neuropsychiatry, and will be led by Deputy Editor Rebecca Wright. Neurological conditions are the leading causes of disability-adjusted life years worldwide, and account for 9 million deaths annually (data from WHO) with the burden disproportionately affecting low- and middle-income countries. Both journals will prioritise global representation of their research communities with their content and across their Editorial Boards.
For more information about the Nature Progress series, please see here.
Springer Nature is one of the leading publishers of research in the world. We publish the largest number of journals and books and are a pioneer in open research. Through our leading brands, trusted for more than 180 years, we provide technology-enabled products, platforms and services that help researchers to uncover new ideas and share their discoveries, health professionals to stay at the forefront of medical science, and educators to advance learning. We are proud to be part of progress, working together with the communities we serve to share knowledge and bring greater understanding to the world. For more information, please visit about.springernature.com and @SpringerNature.
Nature Portfolio’s high-quality products and services across the life, physical, chemical and applied sciences are dedicated to serving the scientific community.
Nature (founded in 1869) is the leading, international weekly journal of science. Nature Portfolio is also home to the Nature research and Nature Reviews journals, the leading open access multidisciplinary journal Nature Communications, and open access journals including Scientific Reports. Together, these journals publish some of the world's most significant scientific discoveries.
Online, nature.com provides over nine million unique visitors per month with Nature Portfolio content, including news and comment from Nature, and the leading scientific jobs board, Nature Careers. Nature Portfolio also offers a range of researcher services, including online and in-person training and expert language and editing services. For more information, please visit nature.com and follow @Nature. Nature Portfolio is part of Springer Nature.
Katie Baker | External Communications | Springer Nature
katie.baker@springernature.com
